Details of the Drug Formulations

General Information of Drug (ID: DMXWOCP)

• Drug Name: Ethotoin Drug Info
• Synonyms: Accenon; Ethotoine; Ethotoinum; Etotoina; Peganone; Pegoanone; Abbott brand of ethotoin; Accenon (TN); Ethotoine [INN-French]; Ethotoinum [INN-Latin]; Etotoina [INN-Spanish]; Peganone (TN); Ethotoin [INN:BAN:JAN]; Ethotoin (JAN/USP/INN); (+-)-3-Ethyl-5-phenylhydantoin; 1-Ethyl-2,5-dioxo-4-phenylimidazolidine; 3-Ethyl-5-phenyl-2,4-imidazolidinedione; 3-Ethyl-5-phenylhydantoin; 3-Ethyl-5-phenylimidazolidin-2,4-dione; 3-ethyl-5-phenylimidazolidine-2,4-dione

Indication

Disease Entry	ICD 11	Status	REF
Complex partial seizure	8A68.0	Approved	[1]
Epilepsy with generalized tonic-clonic seizures		Approved	[2]

• Therapeutic Class: Anticonvulsants
• Cross-matching ID:
  PubChem CID: 3292
  ChEBI ID: CHEBI:4888
  CAS Number: 86-35-1
  TTD ID: D05EPM
  ACDINA ID: D00255

Full List of Drug Formulations Containing This Drug

Ethotoin 250 mg tablet

Company	Formulation ID	FDA Description
Lundbeck Pharmaceuticals	F07712	Stearic acid; Lactose; Talc; Carboxymethylcellulose sodium; Acacia
Recordati Rare Diseases	F07711	Stearic acid; Lactose, unspecified form; Talc; Acacia; Carboxymethylcellulose sodium, unspecified form

References

• [1] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7183).
• [2] Ethotoin FDA Label